Atlantic Union Bankshares Corp Acquires 5,610 Shares of Align Technology, Inc. $ALGN

Atlantic Union Bankshares Corp lifted its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4,675.0% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,730 shares of the medical equipment provider’s stock after buying an additional 5,610 shares during the quarter. Atlantic Union Bankshares Corp’s holdings in Align Technology were worth $718,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. Ninety One UK Ltd increased its stake in Align Technology by 18.3% in the third quarter. Ninety One UK Ltd now owns 2,267,192 shares of the medical equipment provider’s stock valued at $283,898,000 after purchasing an additional 350,883 shares in the last quarter. Federated Hermes Inc. grew its stake in shares of Align Technology by 31.0% in the 2nd quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider’s stock valued at $175,458,000 after buying an additional 219,219 shares during the period. Disciplined Growth Investors Inc. MN increased its position in Align Technology by 0.9% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 844,987 shares of the medical equipment provider’s stock valued at $159,981,000 after buying an additional 7,754 shares in the last quarter. Norges Bank acquired a new position in Align Technology during the 2nd quarter worth approximately $155,297,000. Finally, Navera Investment Management Ltd. raised its stake in Align Technology by 3.0% during the 2nd quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider’s stock worth $149,126,000 after buying an additional 23,080 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Align Technology Price Performance

ALGN opened at $161.30 on Thursday. Align Technology, Inc. has a 1 year low of $122.00 and a 1 year high of $232.20. The company has a market capitalization of $11.57 billion, a price-to-earnings ratio of 31.26, a P/E/G ratio of 1.76 and a beta of 1.84. The firm’s fifty day moving average price is $161.89 and its two-hundred day moving average price is $148.59.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.30. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the firm earned $2.44 earnings per share. The firm’s revenue was up 5.3% on a year-over-year basis. As a group, equities analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have commented on ALGN. Jefferies Financial Group raised their price objective on Align Technology from $140.00 to $155.00 in a research note on Thursday, October 30th. UBS Group decreased their price target on shares of Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research note on Thursday, October 16th. Piper Sandler restated an “overweight” rating and set a $200.00 price objective (up previously from $190.00) on shares of Align Technology in a report on Thursday, October 30th. Evercore ISI reduced their price objective on shares of Align Technology from $220.00 to $170.00 and set an “outperform” rating for the company in a report on Tuesday, November 25th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $176.82.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 results beat consensus — GAAP EPS of $3.29 vs. $2.99 expected and revenue of ~$1.048B vs. ~$1.03B expected, showing year-over-year improvement and better-than-forecast profitability. Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Management cited strong demand for dental products (Invisalign system and related digital solutions) as the driver of the beat, which supports revenue momentum going into the new quarter. Align Technology beats fourth-quarter results estimates on dental products demand
• Positive Sentiment: Full press release and reported metrics: total Q4 revenue +5.3% year-over-year and sequential growth; company provided supporting slide deck and call for more detail (useful for investors who want line-of-business and regional breakdowns). Align Technology Announces Fourth Quarter and Fiscal 2025 Financial Results
• Neutral Sentiment: Q1 guidance was reported roughly in line with analyst expectations — this tempers upside from the print (no major beat-and-raise) and means future stock moves will depend on execution and trends called out on the conference call. Align Technology beats fourth-quarter results estimates on dental products demand

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.